CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 93 enrolled
Drug / intervention
BD Directigen EZ Flu A+B +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00821626
NCT00821626N/ACompleted
CompareCT.gov

Utility of Rapid Flu Tests in the Medical Management of Returning Travelers With Fever

University of Lausanne Hospitals·interventional·Posted Jan 13, 2009·Updated Apr 2, 2020

In Brief

A clinical study evaluating BD Directigen EZ Flu A+B and Control for Influenza. Completed, enrolled 93 participants across 2 sites.

Detailed Summary

Influenza is a frequent cause of fever in returning travelers. Usually diagnosis rests on the clinical picture. Rapid flu tests are becoming increasingly popular, although their sensitivity and specificity are suboptimal. The objective of this study is to evaluate if rapid flu tests influence the medical management of returning travelers with fever, a population at intermediate risk for influenza infections.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesSwitzerland
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 13, 2009
Enrollment StartJan 1, 2009
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 17.5 years ago

Interventions

BD Directigen EZ Flu A+Bdevice

Naso-pharyngeal swab and rapid flu test

Controlother

No rapid flu test